How the ageing microenvironment influences tumour progression
Some people notice increased energy or clarity within a few sessions
Patients with multiple high-risk variants often see better long-term outcomes with extended GLP-1 use, while those with fewer genetic risk factors may achieve durable results with temporary treatment plus lifestyle modification
Kim JW, Jeon YJ, Jang MJ, Kim JO, Chong SY, Ko KH, Hwang SG, Oh D, Oh J, Kim NK
Following the end of the continuous enrollment provision on March 31, 2023, states began the process of unwinding (i.e., resuming historically typical eligibility redeterminations and disenrolling individuals found to be no longer eligible for Medicaid), resulting in millions being disenrolled from Medicaid
By 2024, the market for compounded GLP-1s was estimated to have reached $1 billion